Nasdaq

QIAGEN: NeuMoDx Multiplex Test Gets FDA Emergency Use Authorization To Differentiate COVID-19

(RTTNews) - Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test. The ...
WLWT

Customers can get tested for flu, RSV, COVID-19 all at once at Kroger's Little Clinics

Customers can make sure they are getting the right treatment for their illnesses by taking a three-in-one multiplex test at Kroger's Little Clinics that test for the flu, RSV and COVID-19 all at ...
Business Wire

Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...
Nasdaq

FDA Approves Emergency Use For QIAGEN’s NeuMoDx Multiplex Test

QIAGEN’s NeuMoDx test has received emergency use authorization from the U.S. Food and Drug Administration (FDA). The test helps to quickly identify and differentiate individuals suspected of ...
Seeking Alpha

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test

The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers™ and licensed by the CDSCO for use in diagnostic procedures CoSara's new real-time multiplex PCR test is built ...
BioWorld

Lexagene's multiplex test gives answers needed to manage second wave of COVID-19

Beverly, Mass.-based Lexagene Holdings Inc. has developed a genetic analyzer with multiplex testing capability that would enable it to determine whether a patient has COVID-19, influenza or another ...